Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Pleural Effusion, Malignant 1Paranasal Sinus Neoplasms 1Papillomavirus Infections 1Neoplasms 1Nasopharyngeal Carcinoma 1Melanoma 1HIV Infections 1GIST 1Cervical Cancer Screening 1Breast Neoplasms 1

Interventions

Bevacizumab 7Talc 4Pleurodesis 4Thoracoscopy 3Povidone-Iodine 3Paclitaxel 3Drug Therapy 3Doxycycline 3Docetaxel 3Cisplatin 3Chest Tubes 3Carboplatin 3aldesleukin 2Thoracentesis 2Taxes 2Surveys and Questionnaires 2Sodium Chloride 2Silver Nitrate 2Pharmaceutical Preparations 2Nivolumab 2Magnetic Resonance Spectroscopy 2Interleukin-2 2High-Energy Shock Waves 2Gemcitabine 2Fentanyl 2tocilizumab 1talimogene laherparepvec 1romidepsin 1lipoplatin 1cediranib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pleural Effusion, Malignant × Coal Tar × Clear all
NCT02132884 2019-09-04

Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Fox Chase Cancer Center

Phase NA Terminated
1 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡